ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
513 hedge funds and large institutions have $34.9B invested in Alexion Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 226 increasing their positions, 169 reducing their positions, and 73 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
44% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 73
47% less call options, than puts
Call options by funds: $121M | Put options by funds: $228M
Holders
513
Holding in Top 10
19
Calls
$121M
Puts
$228M
Top Buyers
| 1 | +$272M | |
| 2 | +$227M | |
| 3 | +$190M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$168M |
| 5 |
Jennison Associates
New York
|
+$143M |
Top Sellers
| 1 | -$196M | |
| 2 | -$162M | |
| 3 | -$83.7M | |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
-$78.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$65.6M |